Will load more when the chart and price action start pointing to continuation.   Going to point out the obvious here, the stock is stalled by the recent financing which in my opinion was at an impressive price given the short amount of time the stock has traded up at this level.  You almost always see dilution announced at a big discount.  Given the strength over at Viemed it's just a matter of days we see the big break on this name.  I suspect momentum picks up to the upside once they close their financing on Tuesday.  Cheers